1. Home
  2. EHC vs PCVX Comparison

EHC vs PCVX Comparison

Compare EHC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Encompass Health Corporation

EHC

Encompass Health Corporation

HOLD

Current Price

$106.22

Market Cap

10.6B

Sector

Health Care

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$52.78

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHC
PCVX
Founded
1983
2013
Country
United States
United States
Employees
29944
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
8.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
EHC
PCVX
Price
$106.22
$52.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$143.29
$88.25
AVG Volume (30 Days)
899.3K
1.2M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
0.74%
N/A
EPS Growth
24.22
N/A
EPS
1.93
N/A
Revenue
N/A
N/A
Revenue This Year
$9.33
N/A
Revenue Next Year
$8.14
N/A
P/E Ratio
$55.42
N/A
Revenue Growth
N/A
N/A
52 Week Low
$92.77
$28.64
52 Week High
$127.99
$65.00

Technical Indicators

Market Signals
Indicator
EHC
PCVX
Relative Strength Index (RSI) 56.07 36.53
Support Level $105.92 $52.04
Resistance Level $109.24 $56.04
Average True Range (ATR) 3.22 2.68
MACD 0.33 -0.92
Stochastic Oscillator 72.11 32.17

Price Performance

Historical Comparison
EHC
PCVX

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: